-
How Can CROs Gain Buy-in from Pharma for Investment in R&D Innovation?
Article Preview
-
Contract Development and Manufacturing Due Diligence
Challenge: An international private equity firm was looking at acquiring a Contract Development and Manufacturing Organization and needed to understand -
Brand Strategy
Situation: A fully integrated Contract Development and Manufacturing Organization was merging with a company with overlapping capabilities and requested that -
Market Opportunity Assessment
Situation: A global CMO offering aseptic fill/finish capabilities was interested in entering the small molecule API manufacturing market and contracted -
Pricing Strategy Optimization
Situation: A leading Contract Research Organization retained Kineticos to conduct an in-depth pricing analysis, which would influence a data-driven pricing -
Comparative Advantage Analysis
Situation: A leading global provider of product development services retained Kineticos to better align its market positioning with customer needs -
Commercial Review for a Clinical Research Organization
Situation: A global clinical research organization (CRO) was experiencing stagnating growth in their bioanalytical, central and cGMP laboratories. When it
-
Growth by Acquisition in Life Sciences: Do You Have a Plan?
Article Preview As the life sciences landscape continually changes, growth by acquisition has become increasingly common. Recent deals, such as -
Driving Revenue and EBIDTA at CROs through Customer Loyalty
Article Preview Determining customer satisfaction and loyalty is a difficult endeavor for most businesses. Traditional voice of customer surveys are -
Foundation Medicine and Clovis Expand Partnership
Article Preview In April 2014, Foundation Medicine and Clovis Oncology announced the expansion of their partnership by developing a companion -
LabCorp to Acquire LipoScience
Article Preview Laboratory Corporation of America Holdings is making a strong bid to expand its personalized medicine offering by adding -
ICON and Medidata Partner to Offer Electronic Patient Reported Outcomes
Article Preview Over the past year, I have written many blogs about building partnerships with external service providers. When we -
NICE’s New Clinical Data Requirement: Effect on Biomarker Use in Clinical Trials?
Article Preview The UK’s NICE (National Institute for Health and Care Excellence) has for some time been the leader among